| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future?
|
Phillips, Gordon L.
|
|
2012
|
36 |
12 |
p. 1490-1495
6 p.
|
artikel
|
| 2 |
Can we safely discontinue imatinib? Searching for new endpoints in CML: A standardized definition of “cure”
|
Breccia, Massimo
|
|
2012
|
36 |
12 |
p. 1498-1499
2 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2012
|
36 |
12 |
p. CO2-
1 p.
|
artikel
|
| 4 |
Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells
|
Chen, Jing
|
|
2012
|
36 |
12 |
p. 1526-1535
10 p.
|
artikel
|
| 5 |
Enhancement of antigen presenting ability in the leukemic plasmacytoid dendritic cell line (PMDC05) by lentiviral vector-mediated transduction of CD80 gene
|
Yamahira, Akie
|
|
2012
|
36 |
12 |
p. 1541-1546
6 p.
|
artikel
|
| 6 |
Historical perspectives on myelodysplastic syndromes
|
Steensma, David P.
|
|
2012
|
36 |
12 |
p. 1441-1452
12 p.
|
artikel
|
| 7 |
IGH@/BCL6 rearrangement on the der(3)t(3;14)(q27;q32) in primary mediastinal large B-cell lymphoma
|
Yamamoto, Katsuya
|
|
2012
|
36 |
12 |
p. e218-e221
nvt p.
|
artikel
|
| 8 |
Imatinib increases apoptosis index through modulation of survivin subcellular localization in the blast phase of CML cells
|
Bernardo, Paula Sabbo
|
|
2012
|
36 |
12 |
p. 1510-1516
7 p.
|
artikel
|
| 9 |
Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells
|
Humbert, Magali
|
|
2012
|
36 |
12 |
p. 1552-1556
5 p.
|
artikel
|
| 10 |
Management of AML: Who do we really cure?
|
Liesveld, Jane
|
|
2012
|
36 |
12 |
p. 1475-1480
6 p.
|
artikel
|
| 11 |
MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma
|
Gao, Xiao
|
|
2012
|
36 |
12 |
p. 1505-1509
5 p.
|
artikel
|
| 12 |
Molecular genetics in myelodysplastic syndromes
|
Haferlach, Torsten
|
|
2012
|
36 |
12 |
p. 1459-1462
4 p.
|
artikel
|
| 13 |
MPN blast phase: Clinical challenge and assessing response
|
Mesa, Ruben A.
|
|
2012
|
36 |
12 |
p. 1496-1497
2 p.
|
artikel
|
| 14 |
Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies
|
Sakaguchi, Hirotoshi
|
|
2012
|
36 |
12 |
p. e215-e217
nvt p.
|
artikel
|
| 15 |
Myeloproliferative neoplasms 2012: The John M. Bennett 80th birthday anniversary lecture
|
Tefferi, Ayalew
|
|
2012
|
36 |
12 |
p. 1481-1489
9 p.
|
artikel
|
| 16 |
New therapeutics for myelodysplastic syndromes
|
List, Alan F.
|
|
2012
|
36 |
12 |
p. 1470-1474
5 p.
|
artikel
|
| 17 |
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen
|
Liew, Elena
|
|
2012
|
36 |
12 |
p. 1517-1520
4 p.
|
artikel
|
| 18 |
Prognostic scoring systems in MDS
|
Germing, Ulrich
|
|
2012
|
36 |
12 |
p. 1463-1469
7 p.
|
artikel
|
| 19 |
Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium
|
Mascarenhas, John
|
|
2012
|
36 |
12 |
p. 1500-1504
5 p.
|
artikel
|
| 20 |
Retreatment with purine analogs in patients with chronic lymphocytic leukemia
|
Dlouhy, Ivan
|
|
2012
|
36 |
12 |
p. 1521-1525
5 p.
|
artikel
|
| 21 |
S-allyl derivatives of 6-mercaptopurine are highly potent drugs against human B-CLL through synergism between 6-mercaptopurine and allicin
|
Miron, Talia
|
|
2012
|
36 |
12 |
p. 1536-1540
5 p.
|
artikel
|
| 22 |
Symposium on Myeloid Neoplasms
|
|
|
2012
|
36 |
12 |
p. 1439-
1 p.
|
artikel
|
| 23 |
Symposium on Myeloid Neoplasms on June 9, 2012 in honor of Dr. John M. Bennett
|
Burack, W. Richard
|
|
2012
|
36 |
12 |
p. 1440-
1 p.
|
artikel
|
| 24 |
The classification of MDS: From FAB to WHO and beyond
|
Vardiman, James
|
|
2012
|
36 |
12 |
p. 1453-1458
6 p.
|
artikel
|
| 25 |
Therapy-related acute myeloid leukemia with favorable cytogenetics: Still favorable?
|
Aldoss, Ibrahim
|
|
2012
|
36 |
12 |
p. 1547-1551
5 p.
|
artikel
|
| 26 |
Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q− MDS (IPSS low and intermediate-1)
|
Jonasova, Anna
|
|
2012
|
36 |
12 |
p. e222-e224
nvt p.
|
artikel
|
Tijdschrift beschrijving